Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.

[1]  Carl W. Miller,et al.  ERCC5 is a novel biomarker of ovarian cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Ogawa,et al.  Molecular allelokaryotyping of early‐stage, untreated chronic lymphocytic leukemia , 2008, Cancer.

[3]  Zachary A. Szpiech,et al.  Genotype, haplotype and copy-number variation in worldwide human populations , 2008, Nature.

[4]  Carl W. Miller,et al.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. , 2007, Blood.

[5]  H. Koeffler,et al.  Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. , 2007, Blood.

[6]  Motohiro Kato,et al.  Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.

[7]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[8]  W. Hiddemann,et al.  Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma , 2006, Genes, chromosomes & cancer.

[9]  Y. Samuels,et al.  Oncogenic PI3K and its role in cancer , 2006, Current opinion in oncology.

[10]  T. Witzig.  Current treatment approaches for mantle-cell lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Rosenwald,et al.  Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[13]  D. Pinkel,et al.  Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. , 2005, Blood.

[14]  D. Loegering,et al.  Proteomic analysis of mantle-cell lymphoma by protein microarray. , 2005, Blood.

[15]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[16]  Rolph Pfundt,et al.  Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. , 2005, Blood.

[17]  G. Ott,et al.  Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. , 2004, Blood.

[18]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[19]  E. Zucca,et al.  Molecular basis of mantle cell lymphoma , 2004, British journal of haematology.

[20]  S. de Vos,et al.  Cell Cycle Alterations in the Blastoid Variant of Mantle Cell Lymphoma (MCL-BV) as Detected by Gene Expression Profiling of Mantle Cell Lymphoma (MCL) and MCL-BV , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[21]  D. Catovsky,et al.  Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene , 2002, Genes, chromosomes & cancer.

[22]  S. de Vos,et al.  Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. , 2001, Blood.

[23]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  A. López-Guillermo,et al.  Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. , 1999, Blood.

[25]  F. Birg,et al.  Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. , 1999, Blood.

[26]  G. Brittinger,et al.  Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. , 1997, Leukemia.

[27]  E. Campo,et al.  Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.

[28]  D. Weisenburger,et al.  Mantle cell lymphoma-- an entity comes of age. , 1996, Blood.

[29]  H. Lovec,et al.  Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.

[30]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[31]  F. Mitelman.  The cytogenetic scenario of chronic myeloid leukemia. , 1993, Leukemia & lymphoma.